FIELD: medicine, obstetrics, gynecology.
SUBSTANCE: at the background of therapy conducted one should introduce derinate immunomodulator into the body of pregnant woman additionally nasally per 1-2 drops of 0.25%-solution into each nasal canal 5-8 times daily for 3-5 d and - parenterally per 5.0 ml of 1.5%-solution once daily for 3-8 d along with preparation that improves microcirculation and along with antioxidant at a certain sequence, moreover, derinate should be introduced 30-40 min after application of microcirculation-improving preparation, and antioxidant - 20-30 min after derinate's introduction. The present innovation favors decreased edemas, decreased body weight, stabilization of Macluer-Aldrich test that in its turn enables to avoid perinatal losses, decrease the risk for the development of fetoplacental insufficiency and intrauterine fetal infection.
EFFECT: higher efficiency of therapy.
1 ex, 2 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| APPLICATION OF A PHOSPHOLIPID EMULSION CONTAINING AN EFFECTIVE AMOUNT OF DIHYDROQUERCETIN FOR TREATING GESTOSES OF THE FIRST TRIMESTER OF PREGNANCY | 2021 | 
 | RU2773682C1 | 
| METHOD FOR PROPHYLAXIS OF TARDY TOXICOSES IN PREGNANT WOMEN | 1991 | 
 | RU2099066C1 | 
| METHOD FOR TREATING MILD FORMS OF LATER GESTOSIS | 1998 | 
 | RU2180208C2 | 
| METHOD FOR TREATING PREGNANCY GESTOSIS | 1995 | 
 | RU2110228C1 | 
| METHOD FOR TREATING LIGHT FORMS OF LATE GESTOSIS OF PREGNANT WOMEN | 1997 | 
 | RU2154446C2 | 
| AGENT FOR TREATMENT OF GESTATION PYELONEPHRITIS | 2001 | 
 | RU2181293C1 | 
| METHOD FOR DETERMINING SEVERITY OF GESTOSIS IN PREGNANT WOMEN | 2012 | 
 | RU2521359C2 | 
| METHOD FOR PREVENTING LATE TOXICOSIS OF PREGNANCY | 1995 | 
 | RU2129863C1 | 
| METHOD FOR PREDICTING REPEATED ARRIVAL OF SEVERE GESTOSIS FORMS | 2003 | 
 | RU2239839C1 | 
| METHOD FOR PREDICTING GESTOSIS | 2004 | 
 | RU2263913C2 | 
Authors
Dates
2005-01-10—Published
2003-08-28—Filed